Skip to main content
. 2014 Jan 16;63(2):483–493. doi: 10.2337/db13-0954

Figure 2.

Figure 2

Glucose (upper panel), insulin (upper middle panel), C-peptide (lower middle panel), and glucagon concentrations (lower panel) during saline infusion and during exendin-9,39 infusion in the post-RYGB (left panel) and control (right panel) groups.